CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-09 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-09 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-09 | Cox Russell J. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-09 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-09 | Milligan Sandra Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-06-09 | GALA RENEE D Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-05-04 | Carter Laura Chief Scientific Officer | Sale | −1,262 | $7.20 | $9K | 89,042 |
| 2022-03-23 | Christian Waage EVP, Tech Ops and Admin | Sale | −10,722 | $8.92 | $96K | 579,008 |
| 2022-03-23 | Hasnain Faheem President & CEO | Sale | −19,035 | $8.92 | $170K | 143,465 |
| 2022-03-23 | Giraudo Bryan COO/CFO | Sale | −10,722 | $8.92 | $96K | 99,167 |
| 2022-03-16 | Carter Laura Chief Scientific Officer | Sale | −5,002 | $8.28 | $41K | 90,304 |
| 2022-03-16 | Peterson Caryn EVP, Regulatory Affairs | Sale | −6,279 | $8.28 | $52K | 66,172 |
| 2022-03-16 | Aranda Richard Chief Medical Officer | Sale | −6,278 | $8.28 | $52K | 211,675 |
| 2022-01-06 | Carter Laura Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-01-06 | Peterson Caryn EVP, Regulatory Affairs | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-01-06 | Aranda Richard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-01-06 | Christian Waage EVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-01-06 | Giraudo Bryan COO/CFO | Grant or award · Stock Option (Right to Buy) | +265,000 | 265,000 | ||
| 2022-01-06 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2021-10-25 | Peterson Caryn EVP, Regulatory Affairs | Sale | −2,377 | $12.25 | $29K | 72,451 |
Page 15 of 21 · 401 trades